Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fulcrum Therapeutics

7.12
-0.1300-1.79%
Post-market: 7.120.00000.00%16:20 EDT
Volume:229.54K
Turnover:1.63M
Market Cap:384.33M
PE:-867.13
High:7.39
Open:7.30
Low:6.99
Close:7.25
Loading ...
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 24, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 25, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]